Clinical data | |
---|---|
Trade names | Marezine, Valoid, Nausicalm, others |
AHFS/Drugs.com | Consumer Drug Information |
Pregnancy category |
|
Routes of administration | By mouth, IM, IV |
ATC code | |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Metabolism | N-demethylated to inactive norcyclizine[1] |
Elimination half-life | 20 hours |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
IUPHAR/BPS | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.001.314 |
Chemical and physical data | |
Formula | C18H22N2 |
Molar mass | 266.388 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
Cyclizine, sold under a number of brand names, is a medication used to treat and prevent nausea, vomiting and dizziness due to motion sickness or vertigo.[2] It may also be used for nausea after general anaesthesia or that which developed from opioid use.[2][3] It is taken by mouth, in the rectum, or injected into a vein.[3][4]
Common side effects include sleepiness, dry mouth, constipation, and trouble with vision.[5] More serious side effects include low blood pressure and urinary retention.[5] It is not generally recommended in young children or those with glaucoma.[2][6] Cyclizine appears to be safe during pregnancy but has not been well studied.[7] It is in the anticholinergic and antihistamine family of medications.[3][6]
Cyclizine was discovered in 1947.[8] It is on the World Health Organization's List of Essential Medicines.[9] In the United States it is available over the counter.[6]